Graham Doyle
Stock Analyst at UBS
(0.54)
# 3,997
Out of 4,429 analysts
403
Total ratings
42.3%
Success rate
-3.3%
Average return
Main Sectors:
Stocks Rated by Graham Doyle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: FME Fresenius Medical Care AG | Maintained: Sell | €37.00 | $40.70 | -9.09% | 53 | Jun 9, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Maintained: Buy | €54.00 | $39.61 | +36.33% | 47 | Jun 3, 2026 | |
| LON: CTEC Convatec Group PLC | Maintained: Buy | 375p | $207.00 | +81.16% | 21 | May 29, 2026 | |
| EPA: BIM bioMérieux S.A. | Maintained: Buy | €138.00 | $69.00 | +100.00% | 1 | May 21, 2026 | |
| LON: 0QBO Coloplast A/S | Maintained: Buy | kr 613.00 → kr 530.00 | $377.40 | +40.43% | 12 | May 21, 2026 | |
| STO: EKTA.B Elekta AB (publ) | Downgraded: Sell | kr 39.00 | $48.54 | -19.65% | 1 | May 21, 2026 | |
| SWX: SOON Sonova Holding AG | Maintained: Hold | CHF 215.00 → CHF 206.00 | $193.20 | +6.63% | 16 | May 21, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Buy | CHF 86.00 | $52.86 | +62.69% | 29 | May 21, 2026 | |
| AMBFF Ambu A/S | Maintained: Buy | $15 | $9.85 | +49.56% | 1 | May 21, 2026 | |
| GEHC GE HealthCare Technologies | Upgraded: Hold | $77 → $69 | $61.59 | +12.03% | 9 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €25.00 | $24.94 | +0.24% | 52 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €51.00 | $34.23 | +48.99% | 46 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €32.50 | $23.50 | +38.30% | 53 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | CHF 87.00 → CHF 72.63 | $104.65 | -30.59% | 16 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 151.00 | $133.80 | +12.86% | 5 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $37 | $35.45 | +3.89% | 7 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,290p → 1,300p | $1,125.00 | +15.56% | 20 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $293.31 | n/a | 2 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $118.30 | n/a | 2 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13,234.00 | n/a | 5 | May 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1,925.50 | n/a | 3 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €90.00 | $37.84 | n/a | 1 | Jan 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 275.00 | $319.80 | n/a | 1 | Jun 20, 2019 |
Fresenius Medical Care AG
Jun 9, 2026
Maintained: Sell
Price Target: €37.00
Current: $40.70
Upside: -9.09%
Fresenius SE & Co. KGaA
Jun 3, 2026
Maintained: Buy
Price Target: €54.00
Current: $39.61
Upside: +36.33%
Convatec Group PLC
May 29, 2026
Maintained: Buy
Price Target: 375p
Current: $207.00
Upside: +81.16%
bioMérieux S.A.
May 21, 2026
Maintained: Buy
Price Target: €138.00
Current: $69.00
Upside: +100.00%
Coloplast A/S
May 21, 2026
Maintained: Buy
Price Target: kr 613.00 → kr 530.00
Current: $377.40
Upside: +40.43%
Elekta AB (publ)
May 21, 2026
Downgraded: Sell
Price Target: kr 39.00
Current: $48.54
Upside: -19.65%
Sonova Holding AG
May 21, 2026
Maintained: Hold
Price Target: CHF 215.00 → CHF 206.00
Current: $193.20
Upside: +6.63%
Alcon Inc.
May 21, 2026
Maintained: Buy
Price Target: CHF 86.00
Current: $52.86
Upside: +62.69%
Ambu A/S
May 21, 2026
Maintained: Buy
Price Target: $15
Current: $9.85
Upside: +49.56%
GE HealthCare Technologies
May 21, 2026
Upgraded: Hold
Price Target: $77 → $69
Current: $61.59
Upside: +12.03%
May 12, 2026
Maintained: Hold
Price Target: €25.00
Current: $24.94
Upside: +0.24%
May 7, 2026
Maintained: Hold
Price Target: €51.00
Current: $34.23
Upside: +48.99%
May 6, 2026
Maintained: Buy
Price Target: €32.50
Current: $23.50
Upside: +38.30%
Apr 30, 2026
Rated: Hold
Price Target: CHF 87.00 → CHF 72.63
Current: $104.65
Upside: -30.59%
Apr 23, 2026
Maintained: Hold
Price Target: CHF 151.00
Current: $133.80
Upside: +12.86%
Apr 15, 2026
Reiterated: Buy
Price Target: $48 → $37
Current: $35.45
Upside: +3.89%
Mar 17, 2026
Maintained: Hold
Price Target: 1,290p → 1,300p
Current: $1,125.00
Upside: +15.56%
Jan 25, 2022
Downgraded: Sell
Price Target: n/a
Current: $293.31
Upside: n/a
Jan 25, 2022
Downgraded: Hold
Price Target: n/a
Current: $118.30
Upside: n/a
May 29, 2020
Reiterated: Buy
Price Target: n/a
Current: $13,234.00
Upside: n/a
May 28, 2020
Reiterated: Hold
Price Target: n/a
Current: $1,925.50
Upside: n/a
Jan 22, 2020
Maintained: Buy
Price Target: €90.00
Current: $37.84
Upside: n/a
Jun 20, 2019
Downgraded: Hold
Price Target: CHF 275.00
Current: $319.80
Upside: n/a